Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment: To Steamroll or Not
NCT ID: NCT04723420
Last Updated: 2023-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2020-08-07
2023-12-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment in Patients With Extended Criteria
NCT02871531
Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment
NCT01639209
Corneal Endothelial Cell Loss After Pneumatic Retinopexy for the Repair of Primary Rhegmatogenous Retinal Detachment
NCT02185469
Retinal Displacement Rates in Pneumatic Retinopexy Versus Pars Plana Vitrectomy For Primary Retinal Detachment
NCT04158622
Retinal Displacement After Pneumatic Versus Vitrectomy for Retinal Detachment (ALIGN)
NCT04089033
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Steamroller Technique
Following intravitreal gas injection, patient positioned face down for 4-6 hours and subsequently patient changes the position of the head so that the bubble is then placed directly over the retina break.
Steamroller technique
Following intravitreal gas injection, patient positioned face down for 4-6 hours and subsequently patient changes the position of the head so that the bubble is then placed directly over the retina break.
Direct Technique
Following intravitreal gas injection, patient is immediately positioned so that the bubble is placed directly over the retina break.
Direct technique
Following intravitreal gas injection, patient is immediately positioned so that the bubble is placed directly over the retina break.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Steamroller technique
Following intravitreal gas injection, patient positioned face down for 4-6 hours and subsequently patient changes the position of the head so that the bubble is then placed directly over the retina break.
Direct technique
Following intravitreal gas injection, patient is immediately positioned so that the bubble is placed directly over the retina break.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Causative breaks over superior 8 clock hours
* Single break or group of breaks
* No or min proliferative vitreoretinopathy (PVR) (Grade A or B)
* Other breaks or lattice in attached retina are allowed
Exclusion Criteria
* PVR Grade C or worse
* Significant media opacity (Vitreous hemorrhage, dense cataract, cornea scar, etc)
* Pre-existing ocular pathology \[macula hole (MH), epiretinal membrane (ERM), cystoid macula edema (CME), age-related macula degeneration, myopic degeneration, advanced glaucoma, uveitis, amblyopia etc\] or previous eye trauma with poor baseline vision
* Previous pars plana vitrectomy
* Age ≤18years old
* Inadequate physical or mental competence to maintain the required postoperative head position
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sunnybrook Health Sciences Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Kenneth Eng
Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment: To Steamroll or Not
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth Eng, MD FRCSC
Role: PRINCIPAL_INVESTIGATOR
Sunnybrook Health Sciences Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
270-2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.